Explanatory Note:
This Amendment No. 9 relates to and amends the Statement of Beneficial Ownership on Schedule 13D/A (“Schedule 13D/A”) of Tang Capital Partners, LP, a Delaware limited partnership, Tang Capital Management, LLC, a Delaware limited liability company, and Kevin C. Tang, a United States citizen (each, a “Reporting Person” and collectively, the “Reporting Persons”), initially filed jointly by the Reporting Persons with the U.S. Securities and Exchange Commission on August 7, 2014, and amended on September 2, 2014, September 30, 2014, December 16, 2014, May 15, 2015, June 24, 2015, August 21, 2015, March 7, 2016 and March 6, 2017 (as amended, the “Statement”), with respect to the Common Stock, $0.0001 par value (the “Common Stock”), of La Jolla Pharmaceutical Company, a California corporation (the “Issuer”).
Items 3 and 5 of the Statement are hereby amended to the extent hereinafter expressly set forth. All capitalized terms used and not expressly defined herein have the respective meanings ascribed to such terms in the Statement.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Statement is hereby amended to add the following:
On March 23, 2017, Tang Capital Partners, LP purchased 149,254 shares of the Issuer’s Common Stock through an underwritten public offering at a price of $33.50 per share.
On December 11, 2017, Kevin C. Tang, in his capacity as a board member of the Issuer, was granted an option to purchase 10,000 shares of the Issuer’s Common Stock at a price of $28.10 per share, subject to vesting conditions.
On February 23, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $31.5413 per share.
On February 23, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $31.9442 per share.
On February 23, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.4186 per share.
On February 23, 2018, Tang Capital Partners, LP purchased 20,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.58 per share.
On February 23, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.3046 per share.
On February 26, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.916 per share.
On February 26, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.4821 per share.
On February 26, 2018, Tang Capital Partners, LP purchased 1,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.502 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 9,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.6982 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $32.1728 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.5714 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.8796 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.8725 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.688 per share.
On February 27, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.6037 per share.
On February 28, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $29.5381 per share.
On February 28, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.1171 per share.
On February 28, 2018, Tang Capital Partners, LP purchased 10,000 shares of the Issuer’s Common Stock through the open market at a weighted-average price of $30.154 per share.
Tang Capital Partners, LP holds some of its shares in commingled margin accounts with various financial institutions, which may extend margin credit to Tang Capital Partners, LP as and when required, to open or carry positions in the margin accounts, subject to applicable federal margin regulations, stock exchange rules and credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the accounts. The margin accounts may from time to time have debit balances. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock reported herein.
After reasonable inquiry and to the best of his or its knowledge and belief, each of the following Reporting Persons certifies that the information set forth in this statement is true, complete and correct.